Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
International Journal of Molecular Sciences|January 28, 2026
Luteolin Enhances Endothelial Barrier Function and Attenuates Myocardial Ischemia-Reperfusion Injury via FOXP1-NLRP3 PathwayHanyan Xie, Xinyi Zhong, Nan Li, et al.Plos Genetics|January 26, 2018
CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memoryTianyu Song, Shenghui Liang, Jiye Liu, et al.Frontiers in Pharmacology|April 11, 2022
Shexiang Tongxin Dropping Pills Promote Macrophage Polarization-Induced Angiogenesis Against Coronary Microvascular Dysfunction <i>via</i> PI3K/Akt/mTORC1 PathwayXiangyu Lu, Junkai Yao, Changxiang Li, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 15, 2022
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathwayQianqian Jiang, Xu Chen, Xue Tian, et al.Acta Biochimica Et Biophysica Sinica|September 17, 2015
Excess TNF-α in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cellsMing Zhu, Lei Lei, Zhenhua Zhu, et al.Acta Biochimica Et Biophysica Sinica|October 1, 2016
Low-level expression of human ACAT2 gene in monocytic cells is regulated by the C/EBP transcription factorsDongqing Guo, Ming Lu, Xihan Hu, et al.Acta Biochimica Et Biophysica Sinica|October 18, 2015
ACAT1 regulates the dynamics of free cholesterols in plasma membrane which leads to the APP-α-processing alterationMing Zhu, Xiaonan Zhao, Jia Chen, et al.Journal of Ethnopharmacology|April 16, 2020
Identification of the active compounds and drug targets of Chinese medicine in heart failure based on the PPARs-RXRα pathwayMingyan Shao, Dongqing Guo, Wenji Lu, et al.Acta Biochimica Et Biophysica Sinica|October 1, 2016
The ACAT2 expression of human leukocytes is responsible for the excretion of lipoproteins containing cholesteryl/steryl estersDongqing Guo, Xiaowei Zhang, Qin Li, et al.Journal of Medicinal Chemistry|February 25, 2026
Discovery of Novel and Potent Dual PARP1/ERK Inhibitors as a Promising Strategy for Cancer TherapyYing Bai, Shiqi Wu, Wenhui Zhang, et al.Pageof 5